Copyright © 2012 Shou-Kui Xiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. J. Adams, D. W. Polson, and S. Franks, “Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism,” British Medical Journal, vol. 293, no. 6543, pp. 355–359, 1986. View at Google Scholar · View at Scopus
2. A. Galluzzo, M. C. Amato, and C. Giordano, “Insulin resistance and polycystic ovary syndrome,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 18, no. 7, pp. 511–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
3. H. J. Teede, S. Hutchison, S. Zoungas, and C. Meyer, “Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS,” Endocrine, vol. 30, no. 1, pp. 45–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
4. K. A. Toulis, D. G. Goulis, G. Mintziori, et al., “Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome,” Human Reproduction Update, vol. 17, no. 6, pp. 741–760, 2011. View at Google Scholar
5. J. C. Lo, S. L. Feigenbaum, J. Yang, A. R. Pressman, J. V. Selby, and A. S. Go, “Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 4, pp. 1357–1363, 2006. View at Publisher · View at Google Scholar · View at Scopus
6. O. Valkenburg, R. P. M. Steegers-Theunissen, H. P. M. Smedts et al., “A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 2, pp. 470–476, 2008. View at Publisher · View at Google Scholar · View at Scopus
7. R. Freeman, R. Pollack, and E. Rosenbloom, “Assessing impaired glucose tolerance and insulin resistance in polycystic ovarian syndrome with a muffin test: an alternative to the glucose tolerance test,” Endocrine Practice, vol. 16, no. 5, pp. 810–817, 2010. View at Publisher · View at Google Scholar · View at Scopus
8. K. Farrell and M. H. Antoni, “Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions,” Fertility and Sterility, vol. 94, no. 5, pp. 1565–1574, 2010. View at Publisher · View at Google Scholar · View at Scopus
9. F. Ovalle and R. Azziz, “Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus,” Fertility and Sterility, vol. 77, no. 6, pp. 1095–1105, 2002. View at Publisher · View at Google Scholar · View at Scopus
10. S. E. Karakas, K. Kyoungmi, and A. J. Duleba, “Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndrome,” Diabetes Care, vol. 33, no. 4, pp. 887–893, 2010. View at Publisher · View at Google Scholar · View at Scopus
11. S. Eisenhardt, N. Schwarzmann, V. Henschel et al., “Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 3, pp. 946–952, 2006. View at Publisher · View at Google Scholar · View at Scopus
12. D. Dereli, T. Dereli, F. Bayraktar, A. G. Ozgen, and C. Yilmaz, “Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease,” Endocrine Journal, vol. 52, no. 3, pp. 299–308, 2005. View at Publisher · View at Google Scholar · View at Scopus
13. Q. Wang, T. Guo, Y. Tao, Y. Song, and W. Huang, “Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome,” Gynecological Endocrinology, vol. 27, no. 11, pp. 931–934, 2011. View at Google Scholar
14. R. Azziz, “Editorial: polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 9, pp. 4085–4087, 2002. View at Publisher · View at Google Scholar · View at Scopus
15. K. H. Park, J. Y. Kim, C. W. Ahn, Y. D. Song, S. K. Lim, and H. C. Lee, “Polycystic ovarian syndrome (PCOS) and insulin resistance,” International Journal of Gynecology and Obstetrics, vol. 74, no. 3, pp. 261–267, 2001. View at Publisher · View at Google Scholar · View at Scopus
16. M. L. Traub, “Assessing and treating insulin resistance in women with polycystic ovarian syndrome,” World Journal of Diabetes, vol. 2, no. 3, pp. 33–40, 2011. View at Google Scholar
17. P. Saxena, A. Prakash, and A. Nigam, “Efficacy of 2-hour post glucose insulin levels in predicting insulin resistance in polycystic ovarian syndrome with infertility,” Journal of Human Reproductive Sciences, vol. 4, no. 1, pp. 20–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
18. A. Kalra, S. Nair, and L. Rai, “Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome,” Indian Journal of Medical Sciences, vol. 60, no. 11, pp. 447–453, 2006. View at Google Scholar · View at Scopus
19. S. Tangvarasittichai, P. Poonsub, and O. Tangvarasittichai, “Association of serum lipoprotein ratios with insulin resistance in type 2 diabetes mellitus,” Indian Journal of Medical Research, vol. 131, no. 5, pp. 641–648, 2010. View at Google Scholar · View at Scopus
20. A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden, “Relationship between serum lipoprotein ratios and insulin resistance in obesity,” Clinical Chemistry, vol. 50, no. 12, pp. 2316–2322, 2004. View at Publisher · View at Google Scholar · View at Scopus